Federal Supply Schedule V797D70076
Award Date
2/1/17
Last Date to Order
11/30/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Collegium Pharmaceutical Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Aquestive Therapeutics, Inc. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products, under FSS Contract 65 I B. The contract has a ceiling value of $1,000,000.00 and a period of performance extending to March 31, 2030. As a multiple award FSS contract, this vehicle allows the VA and other federal agencies to procure the specified pharmaceutical and drug...
The Federal Supply Schedule contract ID 36F79725D0095 was awarded by the Department of Veterans Affairs (VA) to Avadel CNS Pharmaceuticals, LLC, a for-profit foreign-owned organization. The contract is a multiple-award Federal Supply Schedule (FSS) for "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" with a total ceiling value of $225,000. The period of performance is from June 15, 2025 to June 14, 2030. This FSS contract allows the VA and other authorized federal agencies...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA), provides Supernus Pharmaceuticals, Inc. a five-year, $132.6 million ceiling to supply drugs, pharmaceuticals, and hematology-related products to VA medical facilities. As a multiple award schedule (MAS) contract under FSS-61-IB, it allows the VA to directly order pre-negotiated products from Supernus's catalog to efficiently meet the...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Axsome Therapeutics Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The $25,000 contract has a period of performance through February 28, 2023. As a multiple award FSS, this contract allows for orders to be placed by any federal agency. The contract does not utilize any set-asides. This interim agreement under the FSS facilitates the...
This Federal Supply Schedule (FSS) contract, awarded to First Nation Group LLC, a veteran-owned and service-disabled veteran-owned small business, provides drugs, pharmaceuticals, and hematology-related products to the Department of Veterans Affairs (VA) and its Veterans Integrated Service Network 12 (VISN 12). The $225,000.00 contract has a performance period from September 15, 2024, to September 14, 2029. The price list includes a variety of pharmaceutical products, such as Cyclobenzaprine HCL...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Acertis Pharmaceuticals LLC, a for-profit limited liability company that manufactures goods. The $25,000.00 contract is an interim agreement under FSS Schedule 65 I B, which covers drugs, pharmaceuticals, and hematology-related products. It has a period of performance ending on September 28, 2023. The contract does not use any set-asides and is a multiple...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026. As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Metuchen Pharmaceuticals LLC. The contract is for Pharmaceuticals and Drugs (FSS-61-IB) and has a ceiling value of $6,800,000 with a period of performance through February 14, 2025. The contract aims to procure a variety of pharmaceutical and hematology-related products for the VA's Veterans Integrated Service Network 12. As an FSS contract, it allows for the VA and other federal agencies to...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...